APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025199 pages

Choose your research edition.

Industry ResearchDrugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae include Takeda Pharmaceutical, CSPC, Shenzhen Lijian Pharmaceutical, Sanofi, Merck & Co., Inc. (USA), Roche, Pfizer Inc. (USA), NCPC and Sinopharm Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae market size, projected growth trends, production technologies, key applications, and end-use industries.

Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Segment by Company

Takeda Pharmaceutical

CSPC

Shenzhen Lijian Pharmaceutical

Sanofi

Merck & Co., Inc. (USA)

Roche

Pfizer Inc. (USA)

NCPC

Sinopharm Group

GlaxoSmithKline plc (UK)

Daiichi Sankyo

Bayer

AbbVie

Sun Pharmaceutical

Lupin

Hikma Pharmaceuticals

Dr. Reddy's Laboratories

Cipla

Celltrion

Astellas Pharma Inc. (Japan)

Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Segment by Type

Ceftriaxone

Doxycycline

Other

Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Segment by Application

Retail Pharmacy

Hospital

Other

Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae industry.

Chapter 3: Detailed analysis of Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeaerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Ceftriaxone Table 3. Key Players of Doxycycline Table 4. Key Players of Other Table 4. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Retail Pharmacy Table 6. Key Players of Hospital Table 7. Key Players of Other Table 8. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Region (2021-2026) Table 11. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Region (2027-2032) Table 13. Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Industry Trends Table 14. Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Industry Drivers Table 15. Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Industry Opportunities and Challenges Table 16. Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Industry Restraints Table 17. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue Market Share by Company (2021-2026) Table 19. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Key Company Head Office and Area Served Table 21. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Company, Product Type & Application Table 22. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue Market Share by Type (2021-2026) Table 29. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue Market Share by Type (2027-2032) Table 30. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue Market Share by Application (2021-2026) Table 34. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue Market Share by Application (2027-2032) Table 35. Takeda Pharmaceutical Company Information Table 36. Takeda Pharmaceutical Business Overview Table 37. Takeda Pharmaceutical Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Takeda Pharmaceutical Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio Table 39. Takeda Pharmaceutical Recent Development Table 40. CSPC Company Information Table 41. CSPC Business Overview Table 42. CSPC Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. CSPC Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio Table 44. CSPC Recent Development Table 45. Shenzhen Lijian Pharmaceutical Company Information Table 46. Shenzhen Lijian Pharmaceutical Business Overview Table 47. Shenzhen Lijian Pharmaceutical Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Shenzhen Lijian Pharmaceutical Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio Table 49. Shenzhen Lijian Pharmaceutical Recent Development Table 50. Sanofi Company Information Table 51. Sanofi Business Overview Table 52. Sanofi Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Sanofi Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio Table 54. Sanofi Recent Development Table 55. Merck & Co., Inc. (USA) Company Information Table 56. Merck & Co., Inc. (USA) Business Overview Table 57. Merck & Co., Inc. (USA) Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Merck & Co., Inc. (USA) Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio Table 59. Merck & Co., Inc. (USA) Recent Development Table 60. Roche Company Information Table 61. Roche Business Overview Table 62. Roche Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Roche Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio Table 64. Roche Recent Development Table 65. Pfizer Inc. (USA) Company Information Table 66. Pfizer Inc. (USA) Business Overview Table 67. Pfizer Inc. (USA) Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Pfizer Inc. (USA) Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio Table 69. Pfizer Inc. (USA) Recent Development Table 70. NCPC Company Information Table 71. NCPC Business Overview Table 72. NCPC Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. NCPC Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio Table 74. NCPC Recent Development Table 75. Sinopharm Group Company Information Table 76. Sinopharm Group Business Overview Table 77. Sinopharm Group Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Sinopharm Group Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio Table 79. Sinopharm Group Recent Development Table 80. GlaxoSmithKline plc (UK) Company Information Table 81. GlaxoSmithKline plc (UK) Business Overview Table 82. GlaxoSmithKline plc (UK) Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. GlaxoSmithKline plc (UK) Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio Table 84. GlaxoSmithKline plc (UK) Recent Development Table 85. Daiichi Sankyo Company Information Table 86. Daiichi Sankyo Business Overview Table 87. Daiichi Sankyo Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Daiichi Sankyo Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio Table 89. Daiichi Sankyo Recent Development Table 90. Bayer Company Information Table 91. Bayer Business Overview Table 92. Bayer Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Bayer Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio Table 94. Bayer Recent Development Table 95. AbbVie Company Information Table 96. AbbVie Business Overview Table 97. AbbVie Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. AbbVie Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio Table 99. AbbVie Recent Development Table 100. Sun Pharmaceutical Company Information Table 101. Sun Pharmaceutical Business Overview Table 102. Sun Pharmaceutical Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. Sun Pharmaceutical Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio Table 104. Sun Pharmaceutical Recent Development Table 105. Lupin Company Information Table 106. Lupin Business Overview Table 107. Lupin Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. Lupin Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio Table 109. Lupin Recent Development Table 110. Hikma Pharmaceuticals Company Information Table 111. Hikma Pharmaceuticals Business Overview Table 112. Hikma Pharmaceuticals Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue and Gross Margin (US$ Million) & (2021-2026) Table 113. Hikma Pharmaceuticals Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio Table 114. Hikma Pharmaceuticals Recent Development Table 115. Dr. Reddy's Laboratories Company Information Table 116. Dr. Reddy's Laboratories Business Overview Table 117. Dr. Reddy's Laboratories Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue and Gross Margin (US$ Million) & (2021-2026) Table 118. Dr. Reddy's Laboratories Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio Table 119. Dr. Reddy's Laboratories Recent Development Table 120. Cipla Company Information Table 121. Cipla Business Overview Table 122. Cipla Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue and Gross Margin (US$ Million) & (2021-2026) Table 123. Cipla Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio Table 124. Cipla Recent Development Table 125. Celltrion Company Information Table 126. Celltrion Business Overview Table 127. Celltrion Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue and Gross Margin (US$ Million) & (2021-2026) Table 128. Celltrion Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio Table 129. Celltrion Recent Development Table 130. Astellas Pharma Inc. (Japan) Company Information Table 131. Astellas Pharma Inc. (Japan) Business Overview Table 132. Astellas Pharma Inc. (Japan) Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue and Gross Margin (US$ Million) & (2021-2026) Table 133. Astellas Pharma Inc. (Japan) Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio Table 134. Astellas Pharma Inc. (Japan) Recent Development Table 135. North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Type (2021-2026) & (US$ Million) Table 136. North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Type (2027-2032) & (US$ Million) Table 137. North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Application (2021-2026) & (US$ Million) Table 138. North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Application (2027-2032) & (US$ Million) Table 139. North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Country (2021-2026) Table 141. North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Country (2027-2032) Table 142. Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Type (2021-2026) & (US$ Million) Table 143. Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Type (2027-2032) & (US$ Million) Table 144. Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Application (2021-2026) & (US$ Million) Table 145. Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Application (2027-2032) & (US$ Million) Table 146. Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Country (2021-2026) Table 148. Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Country (2027-2032) Table 149. China Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Type (2021-2026) & (US$ Million) Table 150. China Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Type (2027-2032) & (US$ Million) Table 151. China Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Application (2021-2026) & (US$ Million) Table 152. China Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Application (2027-2032) & (US$ Million) Table 153. Asia Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Type (2021-2026) & (US$ Million) Table 154. Asia Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Type (2027-2032) & (US$ Million) Table 155. Asia Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Application (2021-2026) & (US$ Million) Table 156. Asia Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Application (2027-2032) & (US$ Million) Table 157. Asia Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 158. Asia Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Country (2021-2026) Table 159. Asia Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Country (2027-2032) Table 160. South America, Middle East & Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Type (2021-2026) & (US$ Million) Table 161. South America, Middle East & Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Type (2027-2032) & (US$ Million) Table 162. South America, Middle East & Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Application (2021-2026) & (US$ Million) Table 163. South America, Middle East & Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Application (2027-2032) & (US$ Million) Table 164. South America, Middle East & Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. South America, Middle East & Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Country (2021-2026) Table 166. South America, Middle East & Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Country (2027-2032) Table 167. Research Programs/Design for This Report Table 168. Authors List of This Report Table 169. Secondary Sources Table 170. Primary Sources List of Figures Figure 1. Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Image Figure 2. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Type: 2025 VS 2032 Figure 4. Ceftriaxone Image Figure 5. Doxycycline Image Figure 6. Other Image Figure 7. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Application: 2025 VS 2032 Figure 9. Retail Pharmacy Image Figure 10. Hospital Image Figure 11. Other Image Figure 12. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size (2021-2032) & (US$ Million) Figure 14. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue Market Share by Type (2021-2032) Figure 21. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue Market Share by Application (2021-2032) Figure 23. North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size (2021-2032) & (US$ Million) Figure 24. North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Type (2021-2032) Figure 25. North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Application (2021-2032) Figure 26. North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Country (2021-2032) Figure 27. United States Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size (2021-2032) & (US$ Million) Figure 28. Canada Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size (2021-2032) & (US$ Million) Figure 30. Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size (2021-2032) & (US$ Million) Figure 31. Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Type (2021-2032) Figure 32. Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Application (2021-2032) Figure 33. Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Country (2021-2032) Figure 34. Germany Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size (2021-2032) & (US$ Million) Figure 35. France Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size (2021-2032) & (US$ Million) Figure 37. Italy Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size (2021-2032) & (US$ Million) Figure 38. Russia Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size (2021-2032) & (US$ Million) Figure 40. China Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size (2021-2032) & (US$ Million) Figure 41. China Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Type (2021-2032) Figure 42. China Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Application (2021-2032) Figure 43. Asia Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size (2021-2032) & (US$ Million) Figure 44. Asia Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Type (2021-2032) Figure 45. Asia Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Application (2021-2032) Figure 46. Asia Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Country (2021-2032) Figure 47. Japan Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size (2021-2032) & (US$ Million) Figure 51. India Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size (2021-2032) & (US$ Million) Figure 52. Australia Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Country (2021-2032) Figure 57. Brazil Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size (2021-2032) & (US$ Million) Figure 62. UAE Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size (2021-2032) & (US$ Million) Figure 64. Chile Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Ceftriaxone
  • Doxycycline
  • Other
Applications
  • Retail Pharmacy
  • Hospital
  • Other
Companies covered
  • Takeda Pharmaceutical
  • CSPC
  • Shenzhen Lijian Pharmaceutical
  • Sanofi
  • Merck & Co., Inc. (USA)
  • Roche
  • Pfizer Inc. (USA)
  • NCPC
  • Sinopharm Group
  • GlaxoSmithKline plc (UK)
  • Daiichi Sankyo
  • Bayer
  • AbbVie
  • Sun Pharmaceutical
  • Lupin
  • Hikma Pharmaceuticals
  • Dr. Reddy's Laboratories
  • Cipla
  • Celltrion
  • Astellas Pharma Inc. (Japan)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Ceftriaxone
  5. 1.2.3 Doxycycline
  6. 1.2.4 Other
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Retail Pharmacy
  10. 1.3.3 Hospital
  11. 1.3.4 Other
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Growth Trends by Region
  14. 1.5.1 Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Region (2021-2026)
  16. 1.5.3 Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Dynamics
  1. 2.1 Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Industry Trends
  2. 2.2 Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Industry Drivers
  3. 2.3 Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Industry Opportunities and Challenges
  4. 2.4 Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue by Company (2021-2026)
  2. 3.2 Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Key Company Head office and Area Served
  4. 3.4 Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Company, Product Type & Application
  5. 3.5 Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Tier 1, Tier 2, and Tier 3
4 Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market by Type
  1. 4.1 Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Type (2021-2032)
  3. 4.3 Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Share by Type (2021-2032)
5 Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market by Application
  1. 5.1 Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Application (2021-2032)
  3. 5.3 Global Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Takeda Pharmaceutical
  2. 6.1.1 Takeda Pharmaceutical Company Information
  3. 6.1.2 Takeda Pharmaceutical Business Overview
  4. 6.1.3 Takeda Pharmaceutical Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Takeda Pharmaceutical Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio
  6. 6.1.5 Takeda Pharmaceutical Recent Developments
  7. 6.2 CSPC
  8. 6.2.1 CSPC Company Information
  9. 6.2.2 CSPC Business Overview
  10. 6.2.3 CSPC Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 CSPC Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio
  12. 6.2.5 CSPC Recent Developments
  13. 6.3 Shenzhen Lijian Pharmaceutical
  14. 6.3.1 Shenzhen Lijian Pharmaceutical Company Information
  15. 6.3.2 Shenzhen Lijian Pharmaceutical Business Overview
  16. 6.3.3 Shenzhen Lijian Pharmaceutical Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Shenzhen Lijian Pharmaceutical Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio
  18. 6.3.5 Shenzhen Lijian Pharmaceutical Recent Developments
  19. 6.4 Sanofi
  20. 6.4.1 Sanofi Company Information
  21. 6.4.2 Sanofi Business Overview
  22. 6.4.3 Sanofi Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Sanofi Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio
  24. 6.4.5 Sanofi Recent Developments
  25. 6.5 Merck & Co., Inc. (USA)
  26. 6.5.1 Merck & Co., Inc. (USA) Company Information
  27. 6.5.2 Merck & Co., Inc. (USA) Business Overview
  28. 6.5.3 Merck & Co., Inc. (USA) Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Merck & Co., Inc. (USA) Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio
  30. 6.5.5 Merck & Co., Inc. (USA) Recent Developments
  31. 6.6 Roche
  32. 6.6.1 Roche Company Information
  33. 6.6.2 Roche Business Overview
  34. 6.6.3 Roche Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Roche Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio
  36. 6.6.5 Roche Recent Developments
  37. 6.7 Pfizer Inc. (USA)
  38. 6.7.1 Pfizer Inc. (USA) Company Information
  39. 6.7.2 Pfizer Inc. (USA) Business Overview
  40. 6.7.3 Pfizer Inc. (USA) Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Pfizer Inc. (USA) Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio
  42. 6.7.5 Pfizer Inc. (USA) Recent Developments
  43. 6.8 NCPC
  44. 6.8.1 NCPC Company Information
  45. 6.8.2 NCPC Business Overview
  46. 6.8.3 NCPC Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 NCPC Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio
  48. 6.8.5 NCPC Recent Developments
  49. 6.9 Sinopharm Group
  50. 6.9.1 Sinopharm Group Company Information
  51. 6.9.2 Sinopharm Group Business Overview
  52. 6.9.3 Sinopharm Group Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Sinopharm Group Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio
  54. 6.9.5 Sinopharm Group Recent Developments
  55. 6.10 GlaxoSmithKline plc (UK)
  56. 6.10.1 GlaxoSmithKline plc (UK) Company Information
  57. 6.10.2 GlaxoSmithKline plc (UK) Business Overview
  58. 6.10.3 GlaxoSmithKline plc (UK) Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 GlaxoSmithKline plc (UK) Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio
  60. 6.10.5 GlaxoSmithKline plc (UK) Recent Developments
  61. 6.11 Daiichi Sankyo
  62. 6.11.1 Daiichi Sankyo Company Information
  63. 6.11.2 Daiichi Sankyo Business Overview
  64. 6.11.3 Daiichi Sankyo Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Daiichi Sankyo Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio
  66. 6.11.5 Daiichi Sankyo Recent Developments
  67. 6.12 Bayer
  68. 6.12.1 Bayer Company Information
  69. 6.12.2 Bayer Business Overview
  70. 6.12.3 Bayer Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Bayer Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio
  72. 6.12.5 Bayer Recent Developments
  73. 6.13 AbbVie
  74. 6.13.1 AbbVie Company Information
  75. 6.13.2 AbbVie Business Overview
  76. 6.13.3 AbbVie Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 AbbVie Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio
  78. 6.13.5 AbbVie Recent Developments
  79. 6.14 Sun Pharmaceutical
  80. 6.14.1 Sun Pharmaceutical Company Information
  81. 6.14.2 Sun Pharmaceutical Business Overview
  82. 6.14.3 Sun Pharmaceutical Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Sun Pharmaceutical Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio
  84. 6.14.5 Sun Pharmaceutical Recent Developments
  85. 6.15 Lupin
  86. 6.15.1 Lupin Company Information
  87. 6.15.2 Lupin Business Overview
  88. 6.15.3 Lupin Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Lupin Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio
  90. 6.15.5 Lupin Recent Developments
  91. 6.16 Hikma Pharmaceuticals
  92. 6.16.1 Hikma Pharmaceuticals Company Information
  93. 6.16.2 Hikma Pharmaceuticals Business Overview
  94. 6.16.3 Hikma Pharmaceuticals Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Hikma Pharmaceuticals Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio
  96. 6.16.5 Hikma Pharmaceuticals Recent Developments
  97. 6.17 Dr. Reddy's Laboratories
  98. 6.17.1 Dr. Reddy's Laboratories Company Information
  99. 6.17.2 Dr. Reddy's Laboratories Business Overview
  100. 6.17.3 Dr. Reddy's Laboratories Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Dr. Reddy's Laboratories Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio
  102. 6.17.5 Dr. Reddy's Laboratories Recent Developments
  103. 6.18 Cipla
  104. 6.18.1 Cipla Company Information
  105. 6.18.2 Cipla Business Overview
  106. 6.18.3 Cipla Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Cipla Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio
  108. 6.18.5 Cipla Recent Developments
  109. 6.19 Celltrion
  110. 6.19.1 Celltrion Company Information
  111. 6.19.2 Celltrion Business Overview
  112. 6.19.3 Celltrion Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Celltrion Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio
  114. 6.19.5 Celltrion Recent Developments
  115. 6.20 Astellas Pharma Inc. (Japan)
  116. 6.20.1 Astellas Pharma Inc. (Japan) Company Information
  117. 6.20.2 Astellas Pharma Inc. (Japan) Business Overview
  118. 6.20.3 Astellas Pharma Inc. (Japan) Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Astellas Pharma Inc. (Japan) Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Product Portfolio
  120. 6.20.5 Astellas Pharma Inc. (Japan) Recent Developments
7 North America
  1. 7.1 North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size (2021-2032)
  2. 7.2 North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Type
  3. 7.2.1 North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Type (2021-2026)
  4. 7.2.2 North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Type (2027-2032)
  5. 7.2.3 North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Type (2021-2032)
  6. 7.3 North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Application
  7. 7.3.1 North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Application (2021-2026)
  8. 7.3.2 North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Application (2027-2032)
  9. 7.3.3 North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Application (2021-2032)
  10. 7.4 North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Country
  11. 7.4.1 North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Country (2021-2026)
  13. 7.4.3 North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Country (2027-2032)
  14. 7.4.4 North America Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size (2021-2032)
  2. 8.2 Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Type
  3. 8.2.1 Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Type (2021-2026)
  4. 8.2.2 Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Type (2027-2032)
  5. 8.2.3 Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Type (2021-2032)
  6. 8.3 Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Application
  7. 8.3.1 Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Application (2021-2026)
  8. 8.3.2 Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Application (2027-2032)
  9. 8.3.3 Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Application (2021-2032)
  10. 8.4 Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Country
  11. 8.4.1 Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Country (2021-2026)
  13. 8.4.3 Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Country (2027-2032)
  14. 8.4.4 Europe Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size (2021-2032)
  2. 9.2 China Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Type
  3. 9.2.1 China Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Type (2021-2026)
  4. 9.2.2 China Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Type (2027-2032)
  5. 9.2.3 China Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Type (2021-2032)
  6. 9.3 China Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Application
  7. 9.3.1 China Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Application (2021-2026)
  8. 9.3.2 China Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Application (2027-2032)
  9. 9.3.3 China Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size (2021-2032)
  2. 10.2 Asia Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Type
  3. 10.2.1 Asia Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Type (2021-2026)
  4. 10.2.2 Asia Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Type (2027-2032)
  5. 10.2.3 Asia Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Type (2021-2032)
  6. 10.3 Asia Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Application
  7. 10.3.1 Asia Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Application (2021-2026)
  8. 10.3.2 Asia Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Application (2027-2032)
  9. 10.3.3 Asia Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Application (2021-2032)
  10. 10.4 Asia Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Country
  11. 10.4.1 Asia Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Country (2021-2026)
  13. 10.4.3 Asia Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Country (2027-2032)
  14. 10.4.4 Asia Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Drugs for Infectious Diseases Caused by Neisseria Gonorrhoeae Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst